ES2093130T3 - Forma de ciclosporin para administracion pulmonar. - Google Patents
Forma de ciclosporin para administracion pulmonar.Info
- Publication number
- ES2093130T3 ES2093130T3 ES92104426T ES92104426T ES2093130T3 ES 2093130 T3 ES2093130 T3 ES 2093130T3 ES 92104426 T ES92104426 T ES 92104426T ES 92104426 T ES92104426 T ES 92104426T ES 2093130 T3 ES2093130 T3 ES 2093130T3
- Authority
- ES
- Spain
- Prior art keywords
- cyclosporin
- lung administration
- well
- crystalline
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919105705A GB9105705D0 (en) | 1991-03-18 | 1991-03-18 | Improvements in or relating to organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2093130T3 true ES2093130T3 (es) | 1996-12-16 |
Family
ID=10691762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92104426T Expired - Lifetime ES2093130T3 (es) | 1991-03-18 | 1992-03-14 | Forma de ciclosporin para administracion pulmonar. |
Country Status (29)
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5837677B2 (ja) * | 1981-01-13 | 1983-08-17 | 松下電器産業株式会社 | 誘導加熱調理器 |
| JPH07111905B2 (ja) * | 1987-07-23 | 1995-11-29 | 株式会社東芝 | 誘導加熱調理器の負荷適否検知回路 |
| KR100277622B1 (ko) * | 1992-06-12 | 2001-01-15 | 이타가키 히로시 | 흡입용 초미립자 분말 및 그의 제조방법 |
| US5512269A (en) * | 1993-06-09 | 1996-04-30 | Burroughs Wellcome, Co. | Method of treating retained pulmonary secretions |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| AU3453897A (en) * | 1996-07-08 | 1998-02-02 | Rhone-Poulenc Rorer Limited | Medicinal cyclosporin-a aerosol solution formulation |
| US6517860B1 (en) | 1996-12-31 | 2003-02-11 | Quadrant Holdings Cambridge, Ltd. | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
| US5898028A (en) * | 1997-03-20 | 1999-04-27 | Novo Nordisk A/S | Method for producing powder formulation comprising an insulin |
| TW581681B (en) * | 1998-02-20 | 2004-04-01 | Nektar Therapeutics | Liquid crystal forms of cyclosporin |
| US20020006901A1 (en) * | 1999-02-05 | 2002-01-17 | Aldo T. Iacono | Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease |
| FI20002217A (fi) * | 1999-12-30 | 2001-07-01 | Orion Yhtymae Oyj | Inhalaatiopartikkelit |
| FI20010115A0 (fi) * | 2001-01-18 | 2001-01-18 | Orion Corp | Menetelmä nanopartikkelien valmistamiseksi |
| KR100978836B1 (ko) * | 2001-10-19 | 2010-08-30 | 이소테크니카 인코포레이티드 | 신규한 시클로스포린 유사체 미세유화액 예비농축물 |
| WO2004069223A2 (en) * | 2003-02-06 | 2004-08-19 | Cipla Ltd | Pharmaceutical compositions comprising immunosuppressants and uses thereof |
| DK1610878T3 (da) * | 2003-02-21 | 2014-12-01 | Univ Bath | Fremgangsmåde til fremstilling af partikler |
| US20050059583A1 (en) * | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| EP1781257B1 (en) * | 2004-08-13 | 2018-12-19 | Emisphere Technologies, Inc. | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| US7135455B2 (en) * | 2004-11-15 | 2006-11-14 | Allergan, Inc | Methods for the therapeutic use of cyclosporine components |
| US7151085B2 (en) | 2004-11-15 | 2006-12-19 | Allergan, Inc. | Therapeutic methods using cyclosporine components |
| US20080114577A1 (en) * | 2005-11-30 | 2008-05-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems associated with nutraceutical related assays |
| US20110145009A1 (en) * | 2005-11-30 | 2011-06-16 | Jung Edward K Y | Methods and systems related to transmission of nutraceutical associatd information |
| US8297028B2 (en) | 2006-06-14 | 2012-10-30 | The Invention Science Fund I, Llc | Individualized pharmaceutical selection and packaging |
| US7927787B2 (en) * | 2006-06-28 | 2011-04-19 | The Invention Science Fund I, Llc | Methods and systems for analysis of nutraceutical associated components |
| US20070124219A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized nutraceutical selection and packaging |
| US20070124176A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
| US7974856B2 (en) | 2005-11-30 | 2011-07-05 | The Invention Science Fund I, Llc | Computational systems and methods related to nutraceuticals |
| US8340944B2 (en) * | 2005-11-30 | 2012-12-25 | The Invention Science Fund I, Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
| US20070136092A1 (en) * | 2005-11-30 | 2007-06-14 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging |
| US8068991B2 (en) * | 2005-11-30 | 2011-11-29 | The Invention Science Fund I, Llc | Systems and methods for transmitting pathogen related information and responding |
| US8000981B2 (en) | 2005-11-30 | 2011-08-16 | The Invention Science Fund I, Llc | Methods and systems related to receiving nutraceutical associated information |
| US20080004905A1 (en) * | 2006-06-28 | 2008-01-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for analysis of nutraceutical associated components |
| US20070289258A1 (en) * | 2006-06-14 | 2007-12-20 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Individualized pharmaceutical selection and packaging |
| US7827042B2 (en) * | 2005-11-30 | 2010-11-02 | The Invention Science Fund I, Inc | Methods and systems related to transmission of nutraceutical associated information |
| US10296720B2 (en) * | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
| US20070174128A1 (en) * | 2005-11-30 | 2007-07-26 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging |
| US20080033763A1 (en) * | 2005-11-30 | 2008-02-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems related to receiving nutraceutical associated information |
| US20080052114A1 (en) * | 2005-11-30 | 2008-02-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods related to nutraceuticals |
| DE102006051512A1 (de) | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
| US20070219127A1 (en) * | 2006-03-20 | 2007-09-20 | Walt John G | Cyclosporin a compositions |
| UA113627C2 (xx) * | 2011-05-27 | 2017-02-27 | Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування | |
| JO3410B1 (ar) | 2011-06-07 | 2019-10-20 | Otsuka Pharma Co Ltd | تركيبة أريبيبرازول مجفف بالتبريد |
| BR112014011768A2 (pt) * | 2011-11-15 | 2017-05-09 | Allergan Inc | forma 2 de ciclosporina a e método de produção da mesma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU203564B (en) * | 1987-12-21 | 1991-08-28 | Sandoz Ag | Process for producing new orthorombos cyclosporin without solvatation |
| CH679119A5 (US08197722-20120612-C00042.png) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
| GB8916901D0 (en) * | 1989-07-24 | 1989-09-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
-
1991
- 1991-03-18 GB GB919105705A patent/GB9105705D0/en active Pending
-
1992
- 1992-03-04 HU HU9200735A patent/HU208492B/hu not_active IP Right Cessation
- 1992-03-12 CH CH807/92A patent/CH685229A5/de not_active IP Right Cessation
- 1992-03-13 GB GB9205554A patent/GB2253853B/en not_active Expired - Fee Related
- 1992-03-14 ES ES92104426T patent/ES2093130T3/es not_active Expired - Lifetime
- 1992-03-14 DE DE4208258A patent/DE4208258B4/de not_active Expired - Lifetime
- 1992-03-14 EP EP92104426A patent/EP0504760B1/en not_active Expired - Lifetime
- 1992-03-14 DK DK92104426.9T patent/DK0504760T3/da active
- 1992-03-16 SK SK785-92A patent/SK279576B6/sk not_active IP Right Cessation
- 1992-03-16 IL IL10124492A patent/IL101244A/en not_active IP Right Cessation
- 1992-03-16 NZ NZ241975A patent/NZ241975A/en unknown
- 1992-03-16 NO NO19921012A patent/NO310754B1/no not_active IP Right Cessation
- 1992-03-16 IE IE920839A patent/IE67627B1/en not_active IP Right Cessation
- 1992-03-16 CZ CS92785A patent/CZ281260B6/cs unknown
- 1992-03-16 CA CA002063106A patent/CA2063106C/en not_active Expired - Lifetime
- 1992-03-16 AU AU12940/92A patent/AU658172B2/en not_active Ceased
- 1992-03-16 FR FR9203116A patent/FR2674249A1/fr active Granted
- 1992-03-16 FI FI921125A patent/FI921125A/fi unknown
- 1992-03-16 MX MX9201141A patent/MX9201141A/es unknown
- 1992-03-17 IT ITRM920181A patent/IT1255040B/it active IP Right Grant
- 1992-03-17 KR KR1019920004494A patent/KR920017644A/ko not_active Application Discontinuation
- 1992-03-17 JP JP4060142A patent/JP2549794B2/ja not_active Expired - Lifetime
- 1992-03-17 RU SU925011418A patent/RU2098122C1/ru active
- 1992-03-17 AT AT0053492A patent/AT404553B/de not_active IP Right Cessation
- 1992-03-17 LU LU88087A patent/LU88087A1/fr unknown
- 1992-03-18 ZA ZA921987A patent/ZA921987B/xx unknown
- 1992-03-19 TW TW081102058A patent/TW215901B/zh active
- 1992-05-20 SA SA92120536A patent/SA92120536B1/ar unknown
-
1994
- 1994-06-06 US US08/254,094 patent/US5719123A/en not_active Expired - Lifetime
-
1996
- 1996-10-30 GR GR960402866T patent/GR3021497T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2093130T3 (es) | Forma de ciclosporin para administracion pulmonar. | |
| CA2024916A1 (en) | Respiratory disorder medicaments comprising salmeterol and fluticasone propionate | |
| ATE216575T1 (de) | Treibgasmischung für eine aerosolzubereitung | |
| ES2176355T3 (es) | Formulaciones de aerosol de peptidos y proteinas. | |
| BR0008699A (pt) | Combinações de formoterol e furoato demometasona para asma | |
| CA2123909A1 (en) | New combination of formoterol and budesonide | |
| BR9808812A (pt) | Composição compreendendo partìculas cristalinas, finamente divididas de budesonida | |
| EP0552256A4 (US08197722-20120612-C00042.png) | ||
| ATE329608T1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
| GB2282140A (en) | Purified forms of DNAse | |
| GB9806632D0 (en) | Peptide factor | |
| BR0008276A (pt) | Combinações de formoterol e propionato de fluticasona para asma | |
| AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
| ATE240344T1 (de) | Nor-pregnane zur induzierung hypothalamischer effekte | |
| DK0416950T3 (da) | Medikamenter | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| ATE271852T1 (de) | Verbesserte inhalationspräparate | |
| ES2093829T3 (es) | Composicion farmaceutica para el tratamiento del asma y de las afecciones de las vias respiratorias. | |
| CA2292902A1 (en) | Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases | |
| DE60036199D1 (de) | Proteaseresistente flint-analoge | |
| ATE284696T1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
| MY111155A (en) | Medicaments | |
| TH55704B (th) | วิธีการสำหรับการเร่งอัตราของการชำระด้วยขนเซลล์เมือก | |
| TH55704A3 (th) | วิธีการสำหรับการเร่งอัตราของการชำระด้วยขนเซลล์เมือก |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 504760 Country of ref document: ES |